The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy.

Saved in:
Bibliographic Details
Title: The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy.
Authors: Chen Y; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Chen S; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Zhang H; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China., Song B; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.; The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China., Xu Y; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.; The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0851
DOI:10.1007/s00262-026-04442-8